GlassScriptPhysician profile
Joel D Macdonald
NPI 1487744090
$5,510.75
in general payments reported to CMS, 2019-2025
20 companies · $1,285 in 2025
The $1,285 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $700 · 2020: $49.26 · 2021: $515 · 2022: $1,231 · 2023: $547 · 2024: $1,184 · 2025: $1,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,528 · Food and Beverage: $1,405 · Education: $83.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,527.77 |
| Food and Beverage | $1,404.96 |
| Education | $83.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,868.48 | 2021-2025 | Stealthstation S8 Platform, Catalyft Pl Expandable Interbody System, Mazor X System |
| Globus Medical, INC. | $857.08 | 2025 | Excelsius Gps |
| Si-Bone, INC. | $767.23 | 2021-2022 | |
| Centinel Spine, LLC | $306.64 | 2022 | |
| Boston Scientific Corporation | $265.89 | 2022-2023 | Vercise |
| Medtronic USA, INC. | $262.96 | 2019 | |
| Gt Medical Technologies, INC | $158.03 | 2025 | Gammatile |
| Aesculap Implant Systems, LLC | $141.76 | 2019 | |
| Carlsmed, INC. | $135.91 | 2025 | Aprevo |
| Biogennix, LLC | $120.43 | 2021 | |
| Cerapedics INC. | $119.86 | 2021-2023 | I-Factor Peptide Enhanced Bone Graft |
| Kls-Martin L.P. | $116.77 | 2021 | |
| Camber Spine Technologies LLC | $93.63 | 2019 | |
| Ctl Medical Corporation | $87.13 | 2019-2020 | |
| Livanova USA, INC. | $71.70 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $57.73 | 2019 | |
| Ani Pharmaceuticals, INC. | $26.25 | 2023 | Purified Cortrophin Gel |
| Integra Lifesciences Corporation | $23.32 | 2019 | |
| Neuropace, INC. | $19.35 | 2024 | |
| Healthmyne, INC. | $10.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Macdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.